EGFR and cancer: Human epidermal growth factor receptor (HER) 1 and 2, which promote cancer cell growth, survival and migration [1, 2], are major target molecules for anti-cancer therapies by chemical compounds [3] and monoclonal antibodies (mAbs) [4].